These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 2412024)

  • 41. Haemorheological effects of ketanserin, a selective 5-HT2 receptor antagonist, in aged, spontaneously hypertensive dogs.
    De Clerck F; Jageneau A; Dom J
    Arch Int Pharmacodyn Ther; 1982 Jul; 258(1):100-15. PubMed ID: 7138138
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Sustained hemodynamic improvement during long-term therapy with levodopa in heart failure: role of plasma catecholamines.
    Rajfer SI; Rossen JD; Nemanich JW; Douglas FL; Davis F; Osinski J
    J Am Coll Cardiol; 1987 Dec; 10(6):1286-93. PubMed ID: 3680799
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Influence of ketanserin pretreatment on the haemodynamic responses to sternotomy.
    Cashman JN; Thompson MA; Bennett A
    Anaesthesia; 1986 May; 41(5):505-10. PubMed ID: 2942050
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Effects of 5-hydroxytryptamine inhibition on gas exchange and pulmonary hemodynamics in acute canine pulmonary embolism.
    Kawai A; Umeda A; Mori M; Takasugi T; Yamaguchi K; Kawashiro T
    Adv Exp Med Biol; 1994; 345():75-82. PubMed ID: 8079783
    [No Abstract]   [Full Text] [Related]  

  • 45. Restoration of post-thrombotic peripheral collateral circulation in the cat by ketanserin, a selective 5-HT2-receptor antagonist.
    Nevelsteen A; De Clerck F; Loots W; De Gryse A
    Arch Int Pharmacodyn Ther; 1984 Aug; 270(2):268-79. PubMed ID: 6486973
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Effect of serotonin receptor blockade on endocrine and cardiovascular responses to head-up tilt in humans.
    Matzen S; Secher NH; Knigge U; Pawelczyk J; Perko G; Iversen H; Bach FW; Warberg J
    Acta Physiol Scand; 1993 Oct; 149(2):163-76. PubMed ID: 8266806
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Blood pressure, 5-OH indoleacetic acid, and vanilmandelic acid excretion and blood platelet aggregation in hypertensive patients treated with ketanserin.
    Dzúrik R; Fetkovská N; Brimichová G; Tison P
    J Cardiovasc Pharmacol; 1985; 7 Suppl 7():S29-31. PubMed ID: 2412052
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Ketanserin and alpha 1-adrenergic antagonism in humans.
    Zabludowski JR; Ball SG; Robertson JI
    J Cardiovasc Pharmacol; 1985; 7 Suppl 7():S123-5. PubMed ID: 2412032
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Effects of the antagonists MDL 72222 and ketanserin on responses of cat carotid body chemoreceptors to 5-hydroxytryptamine.
    Kirby GC; McQueen DS
    Br J Pharmacol; 1984 Sep; 83(1):259-69. PubMed ID: 6487893
    [TBL] [Abstract][Full Text] [Related]  

  • 50. The use of ketanserin, a 5-hydroxytryptamine receptor antagonist, for treatment of postoperative hypertension following coronary artery bypass surgery.
    van der Starre PJ; Scheijgrond HW; Reneman RS; Kolling JB
    Anesth Analg; 1983 Jan; 62(1):63-9. PubMed ID: 6600382
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Hemodynamic response to chronic ketanserin treatment in essential hypertension.
    Fagard R; Fiocchi R; Lijnen P; Staessen J; Amery A
    J Cardiovasc Pharmacol; 1985; 7 Suppl 7():S128-9. PubMed ID: 2412034
    [TBL] [Abstract][Full Text] [Related]  

  • 52. A common uptake system for serotonin and dopamine in human platelets.
    Omenn GS; Smith LT
    J Clin Invest; 1978 Aug; 62(2):235-40. PubMed ID: 670392
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Contractions of isolated canine coronary arteries resistant to S2-serotonergic blockade.
    Cohen RA
    J Pharmacol Exp Ther; 1986 May; 237(2):548-52. PubMed ID: 2939235
    [TBL] [Abstract][Full Text] [Related]  

  • 54. The effect of ketanserin, a specific serotonin antagonist, on burn shock hemodynamic parameters in a porcine burn model.
    Holliman CJ; Meuleman TR; Larsen KR; Port JD; Stanley TH; Pace NL; Warden GD
    J Trauma; 1983 Oct; 23(10):867-71. PubMed ID: 6632010
    [TBL] [Abstract][Full Text] [Related]  

  • 55. 5-HT, alpha-adrenoceptors, and blood pressure. Effects of ketanserin in essential hypertension and autonomic insufficiency.
    Wenting GJ; Woittiez AJ; Man in't Veld AJ; Schalekamp MA
    Hypertension; 1984; 6(1):100-9. PubMed ID: 6319278
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Platelet serotonin in essential hypertension and in mental depression.
    Baudouin-Legros M; Le Quan-Bui KH; Guicheney P; Kamal LA; Meyer P
    J Cardiovasc Pharmacol; 1985; 7 Suppl 7():S12-4. PubMed ID: 2412030
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Endogenous catecholamine levels in chronic heart failure. Relation to the severity of hemodynamic abnormalities.
    Viquerat CE; Daly P; Swedberg K; Evers C; Curran D; Parmley WW; Chatterjee K
    Am J Med; 1985 Mar; 78(3):455-60. PubMed ID: 3976704
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Serotonin and the heart: effects of ketanserin on myocardial function, heart rate, and arrhythmias.
    Saman S; Thandroyen F; Opie LH
    J Cardiovasc Pharmacol; 1985; 7 Suppl 7():S70-5. PubMed ID: 2412064
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Ketanserin without effects on basal anterior pituitary hormone secretion in healthy subjects.
    Gordin A; Mustajoki P; Pelkonen R
    J Endocrinol Invest; 1985 Feb; 8(1):73-5. PubMed ID: 2985688
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Ketanserin alters [3H]serotonin uptake and release in rat hypothalamus.
    Offord SJ; Warwick RO
    Eur J Pharmacol; 1984 Sep; 104(3-4):379-82. PubMed ID: 6499929
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.